NCT04593030View on ClinicalTrials.gov

Replication of the ARISTOTLE Anticoagulant Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

220,518

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

Warfarin

Warfarin dispensing claim is used as the reference

DRUG

Apixaban

Apixaban dispensing claim is used as the exposure

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04593030 - Replication of the ARISTOTLE Anticoagulant Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter